Spark Biomedical News

Sierra Tucson Combats Opioid Withdrawal Using Groundbreaking Wearable Neurostimulation TherapyRead MoreRead More
Dallas-Based Spark Biomedical Gets FDA Clearance for its Drug‑Free Solution to Opioid WithdrawalRead MoreRead More
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy SystemRead MoreRead More
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead MoreRead More
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ SystemRead MoreRead More
Transcutaneous Auricular Neurostimulation (tAN™) for Opioid Withdrawal Selected as a Top Abstract by American Society of Pain and NeuroscienceRead MoreRead More
Nine of the Foremost Pain Management Physicians Join the Spark Biomedical, Inc. Medical Advisory BoardRead MoreRead More
Neurostimulation Clinical Trial Shows Promising Initial Results in Easing Opioid Withdrawal Symptoms in NewbornsRead MoreRead More
Spark Biomedical takes “Best in Show” at 2020 NANSRead MoreRead More
Spark Biomedical Presents and Exhibits at the North American Neuromodulation Society 23rd Annual ConferenceRead MoreRead More